Home Antibody All anti-BACE2 antibodies
Also for BACE2 (NM_012105)
|BACE2 antibody was raised against a peptide corresponding to amino acids near the carboxy terminus of human BACE2.|
||WB: 0.5 - 1 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens beta-site APP-cleaving enzyme 2 (BACE2), transcript variant a|
|AEPLC; ALP56; ASP1; ASP21; BAE2; CDA13; CEAP1; DRAP|
|Accumulation of the amyloid-beta (alphabeta) plaque in the cerebral cortex is a critical event in the pathogenesis of Alzheimer’s disease. alphabeta peptide is generated by proteolytic cleavage of the β-amyloid protein precursor (APP) at beta- and gamma-sites by proteases. The long-sought β-secretase was recently identified by several groups independently and designated beta-site APP cleaving enzyme (BACE) and aspartyl protease 2 (Asp2) (1-4). BACE/Asp2 is a novel transmembrane aspartic protease and co-localizes with APP. A BACE homolog was recently cloned and designated BACE2, Asp1, DRAP (for Down region aspartic protease), and memapsin 1 (4-9). BACE2 also cleaves APP at b-site and at a different site within alphabeta (8). BACE2 locates on chromosome 21q22.3, the so-called ‘Down critical region’, suggesting that BACE2 and alphabeta may also contribute to the pathogenesis of Down syndrome (6,7)|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of BACE2 in human heart tissue lysate in the absence (A) or presence (B) of blocking peptide with BACE2 antibody at 1 ug/ml.
Immunohistochemistry of BACE2 in rat heart tissue with BACE2 antibody at 2 ug/ml.